physiopraxis 2024; 22(09): 36-39
DOI: 10.1055/a-2346-6668
Therapie

Aus dem Leben gerissen – Postakute Infektionssyndrome nach Covid-19

Verena Hackl
,
Kathryn Hoffmann

Mit den vielen Covid-19-Erkrankungen in den letzten Jahren steigen auch die Langzeitfolgen dieser Infektion. Dazu zählen unter anderem das posturale Tachykardiesyndrom, eine Dysfunktion des autonomen Nervensystems, und die Post-Exertional Malaise. Mit unzähligen kardiovaskulären und muskuloskelettalen, aber auch neurologischen Symptomen sind viele Patient*innen häufig nicht mehr in der Lage, ihren Alltag zu bestreiten.



Publikationsverlauf

Artikel online veröffentlicht:
13. September 2024

© 2024. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • Literaturverzeichnis

  • 1 Davis HE, McCorkell L, Vogel JM. et al Long COVID: major findings, mechanisms and recommendations. Nature Reviews Microbiology 2023; 21: 133-146
  • 2 Komaroff AL, Bateman L.. Will COVID-19 Leat to Myalgic Encephalomyelitis/Chronic Fatigue Syndrome?. Frontiers in Medicine. 2021
  • 3 Renz-Polster H, tremblay ME, Bienzle D. et al The Pathobiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: The Case for Neuroglial Failure. Frontiers in Cellular Neuroscience 2022; 16: 888232
  • 4 Woodrow M, Carey C, Ziauddeen N. et al Systematic Review of the Prevalence of Long Covid. Open Forum Infectious diseases 2023; 10: ofad233
  • 5 Blitshteyn S, Whitelaw W. Postular orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infection: a case series of 20 patients. Immunol. Res. 2021; 69: 205-211
  • 6 Seeley MC, Gallagher C, Ong E. et al High incidence of autonomic dysfunction and postural orthostatic tachycardia syndrome in patients with long COVD: Implications for management and health care planning. The American journal of medicine 2023; 29 S0002-9343(23)00402-3
  • 7 Turner S, Asad Khan M, Putrino D. et al Long COVID: pathophysiological factors and abnormalities of coagulation. Trends in Endocrinology and metabolism: TEM 2023; 34: 321-344
  • 8 Fedorowski A, Fanciulli A.. Cardiovascular autonomic dysfunction in post-COVID-19 syndrome: a major health-care burden. Nature Reviews Cardiology 21: 1-17
  • 9 Hoffmann K, Hainzl A, Stingl M. et al Interdisziplinäres, kollaboratives D-A-CH Konsensus-Statement zur Diagnostik und Behandlung von Myalgischer Enzephalomyelitis/Chronischem Fatigue-Syndrom. Wien Klein Wochenschr 2024; 136: 103-123
  • 10 Billig SCI, Schauermann JC, Rolke R. et al Quantitative sensory testing predicts histological small fiber neuropathy in postural tachycardia syndrome. Neurol Clin Pract 2020; 10: 428-434
  • 11 Shibao C, Arzubiaga C, Roberts LJ. et al Hyperadrenergic Postural Tachycardia Syndrome in Mast Cell Activation Disorders. Hypertension 2005; 45: 385-90
  • 12 Shaw BH, Stiles LE, Bourne K. et al The face of postural tachycardia syndrome – insights from a large cross-sectional online community-based survey. Journal of internal medicine 2019; 286: 438-448
  • 13 Leslie K., Clague-Baker N., Hilliard N., Bull M.. A Physiotherapist’s Guide to Understanding and Managing ME/CFS. Jessica Kingsley Publishers 2023
  • 14 Raj SR, Guzman JC, Harvey P. et al Canadian Cardiovascular Society Position Statement on Postural Orthostatic Tachycardia Syndrome (POTS) and Related Disorders of Chronic Orthostatic Intolerance. Canadian Journal of Cardiology 2020; 36: 357-372
  • 15 Thieben MJ, Sandroni P, Sletten DM. et al Postural Orthostatic Tachycardia Syndrome: The Mayo Clinic Experience. Mayo Clin Proc. 2007; 82: 308-13
  • 16 Fedorowski A. Postural orthostatic tachycardia syndrome: clinical presentation, aetiology and management. Journal of internal medicine 2018; 285: 352-366
  • 17 Iftekhar N, Sivan M. Venous insufficiency and acrocyanosis in long COVID: dysautonomia. Lancet 2023; 402: e9
  • 18 Kaufman MR, Chang-Kit L, Ray SR. et al Overactive Bladder and Autonomic Dysfunction: Lower Urinary Tract Symptoms in Females with Postural Tachycardia Syndrome. Neurolog Urodyn 2016; 36: 610-613
  • 19 Baker JR, Incognito AV, Ranada SI. et al Reduced stroke volume and brain perfusion drive postural hyperventilation in postural orthostatic tachycardia syndrome. JACC: Basic to translational science. 2024
  • 20 Blitshteyn S, Fries D. Postural Tachycardia Syndrome is Not Caused by Deconditioning. Pulmonary Circulation 2016; 06: 401
  • 21 Ray SR.. The Postural Tachycardia Syndrome (POTS): Pathophysiology, Diagnosis & Management. Indian Pacing Electrophysiol Journal 2006; 06: 84-99
  • 22 Miglis MG, Larsen N, Muppidi S. Mechanisms of post-prandial symptoms in postural tachycardia syndrome and other updates on recent autonomic research. Clinical Autonomic research: official journal of the clinical autonomic research society 2022; 32: 87-89
  • 23 Cook GA, Sandroni P. Management of headache and chronic pain in POTS. Autonomic neuroscience: basic & clinical 2018; 215: 37-45
  • 24 Raj SR, Bourne KM, Stiles LE. et al Postural orthostatic tachycardia syndrome (POTS): Priorities for POTS care and research from a 2019 National Institutes of Health Expert Consensus Meeting – Part 2. Autonomic neuroscience: basic & clinical 2021; 235: 102836
  • 25 Van Campen L, Verheugt FWA, Rowe PC. et al Cerebral blood flow is reduced in ME/CFS during head-up tilt testing even in the absence of hypotension or tachycardia: A quantitative, controlled study using Doppler echography. Clinical Neurophysiol. Pract 2020; 05: 50-58
  • 26 Garland EM, Rai SR, Black BK. et al The hemodynamic and neurohumoral phenotype of postural tachycardia syndrome. Neurology 2007; 69: 790-8
  • 27 Raj SR, Biaggioni I, Yamhure PC. et al Renin-Aldosterone Paradox and Perturbed Blood Volume Regulation Underlying Postural Tachycardia Syndrome. Circulation 2005; 111: 1574-82
  • 28 Grubb BP. Postural Tachycardia Syndrome. Circulation 2008; 117: 2814-2817
  • 29 Fu Q. Microneurographic research in women. Fron Physiol. 2012; 03: 278
  • 30 Knoop I, Jones AS, Gall N. et al Validation of symptom measures in patients under investigation for postural orthostatic tachycardia syndrome (POTS): The Orthostatic Grading Scale (OGS) and the Symptom Screen for Small-fiber Polyneuropathy (SSS). Auton. Neurosci 2023; 250: 103130
  • 31 Renz-Polster H, Scheibenbogen C. Post-COVID-Syndrom mit Fatigue und Belastungsintoleranz: Myalgische Enzephalomyelitis bzw. Chronisches Fatigue-Syndrom. Inn. Med. 2022; 63: 830-839
  • 32 Vernino S, Bourne KM, Stiles L. et al Postural orthostatic tachycardia syndrome (POTS): State of the science and clinical care from a 2019 National Institutes of Health Expert Consensus Meeting - Part 1. Auton. Neurosci 2021; 235: 102828
  • 33 Dysautonomia International. Postural Orthostatic Tachycardia Syndrome (07.01.2024). Im Internet. http://dysautonomiainternational.org/page.php?ID=30 Stand: 24.07.2024
  • 34 Fu Q, Levine BD. Exercise and Non-Pharmacological Treatment of POTS. Auton Neurosci 2018; 215: 20-27
  • 35 Badran BW, Huffman SM, Dancy M. et al A pilot randomized controlled trial of supervised, at-home, self-administered transcutaneous auricular vagus nerve stimulation (taVNS) to manage long COVID symptoms. Research square 2022; 21: rs.3.rs-1716096
  • 36 Mateo LJ, Chu L, Stevens S. et al Post-exertional symptoms distinguish Myalgic Encephalomyelitis/Chronic Fatigue Syndrome subjects from healthy controls. Work 2020; 66: 265-275
  • 37 Bateman L, Bested AC, Bonilla HF. et al Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Essentials of Diagnosis and Management. Mayo Clin Proc 2021; 96: 2861-2878
  • 38 Appelman B, Charlton BT, Goulding RP. et al Muscle abnormalities worsen after post-exertional malaise in long COVID. Nature Communications 2024: 15
  • 39 Bond J, Nielsen T, Hodges L. Effects of Post-Exertional Malaise on Markers of Arterial Stiffness in Individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. International Journal of Environmental Research and Public Health 2021; 18: 2366
  • 40 Lim EJ, Kang EB, Jang ES. et al The Prospects of the Two-Day Cardiopulmonary Exercise Test (CPET) in ME/CFS Patients: A Meta-Analysis. Journal clin. Med 2020; 09: 4040
  • 41 Ghali A, Lacout C, Ghali M. et al Elevated blood lactate in resting conditions correlate with post-exertional malaise severity in patients with Myalgic encephalomyelitis/Chronic fatigue syndrome. Scientific Reports 2019; 09: 18817
  • 42 Lien K, Johansen B, Veierød MB. et al Abnormal blood lactate accumulation during repeated exercise testing in myalgic encephalomyelitis/chronic fatigue syndrome. Physiol. Rep. 2019; 07: e14138
  • 43 National Institute for Health and Care Excellence (NICE). NICE ME/CFS guideline outlines steps for better diagnosis and management | News | News (12.02.2024). Im Internet. https://www.nice.org.uk/news/article/nice-me-cfs-guideline-outlines-steps-for-better-diagnosis-and-management Stand: 24.07.2024
  • 44 Centers for disease control and prevention (CDC). Treatment of ME/CFS | Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) (12.02.2024). Im Internet. https://www.cdc.gov/me-cfs/treatment/index.html Stand: 24.02.2024
  • 45 Goudsmit EM, Nijs J, Jason LA. et al Pacing as a strategy to improve energy management in myalgic encephalomyelitis/chronic fatigue syndrome: a consensus document. Disabil. Rehabil. 2012; 34: 1140-1147
  • 46 Committee on the Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome; Board on the Health of Select Population; Institute of Medicine. Current Case Definitions and Diagnostic Criteria, Terminology, and Symptom Constructs and Clusters. In: Committee on the Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome; Board on the Health of Select Population; Institute of Medicine. Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Redefining an Illness. National Academies Press 2015
  • 47 Sommerfelt K, Schei T, Seton KA. et al Assessing Functional Capacity in Myalgic Encephalopathy/Chronic Fatigue Syndrome: A Patient-Informed Questionnaire. J. Clin. Med. 2024; 13: 3486
  • 48 Committee on the Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome; Board on the Health of Select Population; Institute of Medicine. Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Redefining an Illness. National Academies Press 2015